From October 1, 2022 to November 21, 2022, the company has repurchased 1,211,505 shares, representing 0.22% for CNY 55.98 million. With this, the company has completed the repurchase of 2,022,344 shares, representing 0.37% for CNY 100 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 CNY | -2.13% |
|
-9.26% | -52.49% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-52.49% | 92Cr | |
+55.32% | 82TCr | |
-6.75% | 35TCr | |
+13.56% | 33TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 23TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.